| Dr Suneel Movva, MD | |
|
18005 Hillside Ave, Jamaica, NY 11432-4727 | |
| (718) 526-6300 | |
| Not Available |
| Full Name | Dr Suneel Movva |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Rheumatology |
| Location | 18005 Hillside Ave, Jamaica, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255694717 | NPI | - | NPPES |
| 04201387 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 279430 (New York) | Primary |
| Entity Name | Advantagecare Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336578772 PECOS PAC ID: 2365735008 Enrollment ID: O20160719000446 |
News Archive
The ROMaN Project, Inc. announces its endorsement of the Food and Drug Administration's (FDA) guidance to utilize risk-based monitoring in clinical trials. Risk-based monitoring focuses attention to the most critical data elements in a study and allocates monitoring resources to the investigator sites with problematic or unproven protocol compliance and/or data integrity.
Locally advanced breast cancer patients who received the same class of neoadjuvant chemotherapy were found to have no evidence of disease at the time of their surgery, or achieved pathological complete response, at the same rate regardless of race, according to researchers at The University of Texas M. D. Anderson Cancer Center.
While nursing homes are the place where an estimated 30 percent of Americans die, there currently exists no way to compare which institutions do a better job at managing end of life care. A new study appearing this week in the Journal of Palliative Medicine is starting a discussion over the need to create end of life quality measures in order to both inform consumers and provide nursing homes with incentive to improve care.
Within weeks, flu will start spreading across North America, sickening millions of people. It will hit people with health problems and weak immune systems hardest, and may kill tens of thousands of them.
A new way of concentrating radiotherapy dose in tumours, while minimising damage to healthy cells, has been proposed in research led by scientists at the University of Strathclyde.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Suneel Movva, MD 55 Water St Fl 12, New York, NY 10041-0004 Ph: (646) 680-2888 | Dr Suneel Movva, MD 18005 Hillside Ave, Jamaica, NY 11432-4727 Ph: (718) 526-6300 |
News Archive
The ROMaN Project, Inc. announces its endorsement of the Food and Drug Administration's (FDA) guidance to utilize risk-based monitoring in clinical trials. Risk-based monitoring focuses attention to the most critical data elements in a study and allocates monitoring resources to the investigator sites with problematic or unproven protocol compliance and/or data integrity.
Locally advanced breast cancer patients who received the same class of neoadjuvant chemotherapy were found to have no evidence of disease at the time of their surgery, or achieved pathological complete response, at the same rate regardless of race, according to researchers at The University of Texas M. D. Anderson Cancer Center.
While nursing homes are the place where an estimated 30 percent of Americans die, there currently exists no way to compare which institutions do a better job at managing end of life care. A new study appearing this week in the Journal of Palliative Medicine is starting a discussion over the need to create end of life quality measures in order to both inform consumers and provide nursing homes with incentive to improve care.
Within weeks, flu will start spreading across North America, sickening millions of people. It will hit people with health problems and weak immune systems hardest, and may kill tens of thousands of them.
A new way of concentrating radiotherapy dose in tumours, while minimising damage to healthy cells, has been proposed in research led by scientists at the University of Strathclyde.
› Verified 5 days ago
Dr. David Mallin, M.D. Rheumatology Medicare: Medicare Enrolled Practice Location: 8900 Van Wyck Expy, Jhmc Er, Jamaica, NY 11418 Phone: 718-206-6000 | |
Mark Safford, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 8268 164th St, A-368, Jamaica, NY 11432 Phone: 718-883-4653 | |
Julie Patel-pannullo, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 180-05 Hillside Ave, Jamaica, NY 11432 Phone: 718-526-6300 Fax: 718-262-7064 | |
Dr. Berhane Wubshet, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 9131 175th St, Jamaica, NY 11432 Phone: 718-657-6363 | |
Dr. Rom M Gupta, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 17561 Hillside Ave Ste 402, Jamaica, NY 11432 Phone: 718-291-0488 Fax: 718-291-0888 | |
Dr. Babu M Joseph, M.D Rheumatology Medicare: May Accept Medicare Assignments Practice Location: 10753 Guy R Brewer Blvd, Jamaica, NY 11433 Phone: 718-523-5776 Fax: 718-526-1132 | |
Sailaja Sivareddy, M.D Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 8924 146th St, Jamaica, NY 11435 Phone: 718-715-1764 Fax: 718-885-9311 |